Jefferies Group LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$3,156,026
+541.7%
46,344
+226.4%
0.03%
+766.7%
Q1 2022$491,819
-74.3%
14,198
-81.1%
0.00%
-78.6%
Q3 2021$1,911,000
-1.7%
75,000
+35.1%
0.01%
+16.7%
Q2 2021$1,943,400
-61.8%
55,494
-39.9%
0.01%
-78.9%
Q3 2020$5,092,000
-74.1%
92,351
-70.4%
0.06%
-75.4%
Q2 2020$19,671,000
+88.1%
311,587
+52.2%
0.23%
+98.3%
Q1 2020$10,460,000
+704.0%
204,738
+1150.9%
0.12%
+1070.0%
Q4 2019$1,301,000
-77.1%
16,367
-86.0%
0.01%
-77.3%
Q3 2019$5,676,000
-38.4%
117,000
-33.2%
0.04%
-34.3%
Q2 2019$9,213,000
+210.8%
175,160
+212.8%
0.07%
+179.2%
Q1 2019$2,964,000
-37.3%
56,000
-51.3%
0.02%
-36.8%
Q4 2018$4,724,000
-54.6%
115,057
-58.0%
0.04%
-43.3%
Q3 2018$10,412,000
-17.2%
274,007
-1.5%
0.07%
-4.3%
Q2 2018$12,570,000
+2082.3%
278,100
+1012.4%
0.07%
+2233.3%
Q3 2016$576,000
+21.0%
25,000
-16.7%
0.00%0.0%
Q1 2016$476,00030,0000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders